WEINER RUSSELL J 4

What Happened

• Russell J. Weiner, a director of Clorox Co. (CLX), received two grants of Deferred Stock Units (DSUs) reported as awards: 172.363 units on 2026-02-13 and 325.678 units on 2026-03-31, totaling 498.041 DSUs. Each grant is reported at $0.00 per unit because these are derivative awards, not cash purchases or sales. These DSUs will be settled 1-for-1 in Clorox shares upon the director’s retirement or other termination of service.

Key Details

• Transaction type/code: Award (A) of Deferred Stock Units (derivative instruments).
• Grant dates and amounts: 2026-02-13 — 172.363 DSUs; 2026-03-31 — 325.678 DSUs (total 498.041).
• Reported price: $0.00 per unit (no cash exchanged).
• Settlement: DSUs will be settled 100% in Clorox stock upon the reporting person’s retirement/termination (Footnote F3); 1-for-1 conversion (F1).
• How acquired: DSUs include deferred units acquired via dividend reinvestment and in lieu of quarterly director fees under the Independent Directors' Deferred Compensation Plan (F2, F4).
• Filing: Form 4 filed 2026-04-02 (accession 0001225208-26-004194). The filing reports activity through 2026-03-31; it appears to be a routine, timely disclosure.

Context

• These are director compensation awards (deferred stock units), not open-market purchases or sales — they do not represent shares currently traded on the market and will convert to actual shares only upon settlement events (e.g., retirement).
• Such awards are common for non-employee directors and are typically part of routine pay deferral and dividend reinvestment arrangements; they should not be interpreted as an immediate bullish or bearish market signal.